European Archives - Page 6 of 1103 - European Medical Journal

Biomimetic Hydrogels Revolutionise CAR T Cancer Therapy Production

Biomimetic hydrogels boost CAR T cell production by 50%, cutting cancer therapy costs.

Caffeine Could Help Reduce Cardiovascular Risk in Lupus

A study finds that caffeine intake improves endothelial function in systemic lupus erythematosus by enhancing cell survival and reducing inflammation.

Breakthrough Study Links Parasitic Infection to Cervical Cancer Risk

Research presented at ESCMID Global 2025 reveals how Schistosoma haematobium infection and praziquantel treatment may trigger gene activity linked to cervical cancer risk in women.

Boehringer and Tessellate partner to tackle tough cancer targets

Boehringer Ingelheim and Tessellate Bio form a €500m partnership to develop precision therapies targeting ALT-positive cancers.

Climatic Factors Drive Oropouche Virus Spread Across Latin America

A large-scale study has identified key predictors of Oropouche virus transmission risk across Latin America, providing insights into the 2023–24 outbreak.

Weighing up the Risks: GI Side Effects of Semaglutide vs Tirzepatide

Tirzepatide linked to more GI issues than semaglutide in new study on weight-loss drugs without diabetes. Read more!

5 minutes with... Dr Tami Nussbaum, Takeda

Dr Tami Nussbaum, shares why she left medicine for pharma, the challenges of rare disease and how she avoids burnout.

Which Biologic is Best for Psoriasis Treatment?

A recent clinical trial has compared the effectiveness of IL-17 and IL-23 biologics in treating moderate to severe plaque psoriasis.

Intensive Blood Pressure Control Cuts Dementia Risk by 15%

Blood pressure control over 48 months cuts dementia risk by 15% in a large clinical trial.

Intraoperative Urine Output Similar with Volatile and IV Anaesthesia

Volatile anaesthetics and propofol show no significant difference in intraoperative urine output, study suggests.